Status:
UNKNOWN
Transgender Observational Performance
Lead Sponsor:
Instituto Brasileiro de Controle do Cancer
Conditions:
Transgender Persons
Eligibility:
All Genders
18-50 years
Brief Summary
The study will evaluate the sports capabilities of transgender women mainly in terms of muscular strength and aerobic capacity (VO2max). The control group will be composed of cisgender women and cisge...
Eligibility Criteria
Inclusion
- Diagnosis of a transgender woman by the DSM-V or ICD10.
- Gonadectomized and non-gonadectomized
- Initiation of androgen blockade and/or estrogen use after 12 years of age.
- Age range 18 to 50 years old.
- BMI: 18.0 to 34.9 kg/m2.
- Well-trained individuals (IPAQ very active)
Exclusion
- Current or previous morbidities that could interfere with strength or aerobic tests.
- Chronic illnesses and/or chronic medication use.
- Musculoskeletal limitations.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05337865
Start Date
May 1 2022
End Date
June 1 2023
Last Update
April 20 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.